-
BMO Covered Call Canadian Banks ETF (ZWB $25.32)
-
Hamilton Enhanced Canadian Bank ETF (HCAL $36.97)
-
Kits Eyecare Ltd. (KITS $14.38)
Thank you
KITS has shown nice growth in its company fundamentals recently and analyst estimates continue to trend higher with top-line sales growth expected to be in the 15% to 25% range over the next few years while earnings are expected to show solid expansion. Its margins have inflected positive, and it generates a small amount of free cash flow. Its balance sheet is growing, and we view the recent decline as being a fairly normal pullback in relation to its long-term uptrend. We would be comfortable buying here for a long-term holding, while acknowledging its small size and potential for volatility.
HCAL uses modest 25% leverage, it has a yield of about 4.0%, with $785M in AUM, and an MER of 0.65%. ZWB has a 5.7% yield, no leverage, a solid AUM of $3.8B, and an MER of 0.71%. From a performance standpoint, HCAL has outperformed over the long-term due to its 25% leverage component, but we prefer ZWB due to its higher AUM and no use of leverage. For an investor that is comfortable with leverage and the potential downsides that can bring, we would be OK with HCAL here.
Authors of this answer, directors, partners and/or officers of 5i Research and/or affiliated companies have a financial or other interest in ZWB.